Johnson Chemical Pharmaceutical Works Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 11, 2019 at 10:40 pm IST
Share
Johnson Chemical Pharmaceutical Works Co., Ltd. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 98.403 million compared to TWD 97.328 million a year ago. Operating income was TWD 16.798 million compared to TWD 14.309 million a year ago. Net income was TWD 13.626 million compared to TWD 11.731 million a year ago. Basic earnings per share was TWD 0.45 compared to TWD 0.39 a year ago. For the nine months, sales was TWD 301.142 million compared to TWD 302.311 million a year ago. Operating income was TWD 52.158 million compared to TWD 46.650 million a year ago. Net income was TWD 42.929 million compared to TWD 39.300 million a year ago. Basic earnings per share was TWD 1.43 compared to TWD 1.31 a year ago.
Johnson Chemical Pharmaceutical Works Co., Ltd. is a Taiwan-based company principally engaged in the manufacture and distribution of western medicines and the related raw materials. The Company mainly provides solid dosage forms, including soft and hard capsules, sugar coated tablets, film-coated tablets, suppositories, powder, granules, tablets and others. The Companyâs products include central nervous system drugs, hormones and hormone function medicines, respiratory medicines, gastrointestinal drugs, vitamins and others. The Company mainly distributes its products in Taiwan market and the rest of Asia.
JOHNSON CHEMICAL PHARMACEUTICAL WORKS CO., LTD. 
